UK markets closed

Everest Medicines Limited (1952.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
25.450+1.000 (+4.09%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
125,932
125,932
12,792
54
0
Cost of revenue
34,414
34,414
4,645
23
0
Gross profit
91,518
91,518
8,147
31
0
Operating expenses
Research development
540,054
540,054
809,736
613,433
377,411
Selling general and administrative
396,574
396,574
603,234
440,826
311,079
Total operating expenses
923,453
923,453
1,408,346
1,049,303
687,406
Operating income or loss
-831,935
-831,935
-1,400,199
-1,049,272
-687,406
Interest expense
23,059
23,059
5,591
4,816
23,820
Income before tax
-844,463
-844,463
-247,275
-1,008,719
-5,658,165
Income tax expense
0
0
8
0
0
Income from continuing operations
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Net income
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Net income available to common shareholders
-844,463
-844,463
-247,283
-1,008,719
-5,658,165
Basic EPS
0.03
-2.70
-0.83
-3.44
-66.29
Diluted EPS
0.03
-2.70
-0.83
-3.44
-66.29
Basic average shares
300,775
313,063
297,635
293,272
85,350
Diluted average shares
300,775
313,063
297,635
293,272
85,350